131 related articles for article (PubMed ID: 182913)
21. Polyinosinic-polycytidylic acid treatment of Friend retrovirus-infected mice improves functional properties of virus-specific T cells and prevents virus-induced disease.
Gibbert K; Dietze KK; Zelinskyy G; Lang KS; Barchet W; Kirschning CJ; Dittmer U
J Immunol; 2010 Nov; 185(10):6179-89. PubMed ID: 20943997
[TBL] [Abstract][Full Text] [Related]
22. The gamma interferon (IFN-gamma) mimetic peptide IFN-gamma (95-133) prevents encephalomyocarditis virus infection both in tissue culture and in mice.
Mujtaba MG; Patel CB; Patel RA; Flowers LO; Burkhart MA; Waiboci LW; Martin J; Haider MI; Ahmed CM; Johnson HM
Clin Vaccine Immunol; 2006 Aug; 13(8):944-52. PubMed ID: 16893996
[TBL] [Abstract][Full Text] [Related]
23. Type I interferons protect mice against enterovirus 71 infection.
Liu ML; Lee YP; Wang YF; Lei HY; Liu CC; Wang SM; Su IJ; Wang JR; Yeh TM; Chen SH; Yu CK
J Gen Virol; 2005 Dec; 86(Pt 12):3263-3269. PubMed ID: 16298971
[TBL] [Abstract][Full Text] [Related]
24. An integrated and comparative study of the antiviral effects and other biological properties of the polyinosinic-polycytidylic acid duplex and its mismatched analogues. III. Chronic effects and immunological features.
Carter WA; O'Malley J
Mol Pharmacol; 1976 May; 12(3):440-53. PubMed ID: 180397
[No Abstract] [Full Text] [Related]
25. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010
[TBL] [Abstract][Full Text] [Related]
26. The formation of complexes between polynucleotides, carboxymethylcellulose and polylysine which are anti-viral in mice without inducing interferon.
Stebbing N; Dawson KM
Mol Pharmacol; 1979 Jul; 16(1):313-23. PubMed ID: 225654
[No Abstract] [Full Text] [Related]
27. Encephalomyocarditis virus-induced diabetes mellitus in mice: model of viral pathogenesis.
Jordan GW; Cohen SH
Rev Infect Dis; 1987; 9(5):917-24. PubMed ID: 2825321
[TBL] [Abstract][Full Text] [Related]
28. Differential induction of antiviral effects against West Nile virus in primary mouse macrophages derived from flavivirus-susceptible and congenic resistant mice by alpha/beta interferon and poly(I-C).
Pantelic L; Sivakumaran H; Urosevic N
J Virol; 2005 Feb; 79(3):1753-64. PubMed ID: 15650200
[TBL] [Abstract][Full Text] [Related]
29. Interferon mediated antiviral activity against salmonid fish viruses in BF-2 and other cell lines.
Saint-Jean SR; Pérez-Prieto SI
Vet Immunol Immunopathol; 2006 Mar; 110(1-2):1-10. PubMed ID: 16169598
[TBL] [Abstract][Full Text] [Related]
30. Effect of inapparent murine hepatitis virus infections on macrophages and host resistance.
Dempsey WL; Smith AL; Morahan PS
J Leukoc Biol; 1986 May; 39(5):559-65. PubMed ID: 3009672
[TBL] [Abstract][Full Text] [Related]
31. 2'5' oligo(A) polymerase activity in serum of mice infected with EMC virus or treated with interferon.
Krishnan I; Baglioni C
Nature; 1980 Jun; 285(5765):485-8. PubMed ID: 6157092
[TBL] [Abstract][Full Text] [Related]
32. Identification of antigenic differences between the diabetogenic and non-diabetogenic variants of encephalomyocarditis virus using monoclonal antibodies.
Yoon JW; Ko W; Bae YS; Pak CY; Amano K; Eun HM; Kim MK
J Gen Virol; 1988 May; 69 ( Pt 5)():1085-90. PubMed ID: 2836552
[TBL] [Abstract][Full Text] [Related]
33. Helper-inducer T-lymphocytes mediate diabetes in EMC-infected BALB/c ByJ mice.
Haynes MK; Huber SA; Craighead JE
Diabetes; 1987 Jul; 36(7):877-81. PubMed ID: 2438180
[TBL] [Abstract][Full Text] [Related]
34. Antiviral activity of an extract of Brucella abortus: induction of interferon and immunopotentiation of host resistance.
Kern ER; Glasgow LA; Overall JC
Proc Soc Exp Biol Med; 1976 Jul; 152(3):372-6. PubMed ID: 181760
[No Abstract] [Full Text] [Related]
35. Role of sex and early interferon production in the susceptibility of mice to encephalomyocarditis virus.
Pozzetto B; Gresser I
J Gen Virol; 1985 Apr; 66 ( Pt 4)():701-9. PubMed ID: 2580047
[TBL] [Abstract][Full Text] [Related]
36. Use of viral infections in animal models to assess changes in the immune system.
Kern ER
Environ Health Perspect; 1982 Feb; 43():71-9. PubMed ID: 6174323
[TBL] [Abstract][Full Text] [Related]
37. Rat interferons. VI. Heterologous interferon in the treatment of viral infections.
Lobodzińska M; Albin M
Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):247-52. PubMed ID: 220932
[TBL] [Abstract][Full Text] [Related]
38. Role of Hck in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice.
Choi KS; Jun HS; Kim HN; Park HJ; Eom YW; Noh HL; Kwon H; Kim HM; Yoon JW
J Virol; 2001 Feb; 75(4):1949-57. PubMed ID: 11160694
[TBL] [Abstract][Full Text] [Related]
39. The role of interferon in virus-induced diabetes.
Yoon JW; Cha CY; Jordan GW
J Infect Dis; 1983 Jan; 147(1):155-9. PubMed ID: 6337224
[TBL] [Abstract][Full Text] [Related]
40. Protection of rainbow trout from infectious hematopoietic necrosis (IHN) by injection of infectious pancreatic necrosis virus (IPNV) or poly(I:C).
Kim HJ; Oseko N; Nishizawa T; Yoshimizu M
Dis Aquat Organ; 2009 Feb; 83(2):105-13. PubMed ID: 19326791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
